Scholarly Index
Scott Antonia
Parker Institute for Cancer Immunotherapy; 76,578 total citations; 467 total publications; best world rank #65
Parker Institute for Cancer Immunotherapy
76,578Total citations
467Total publications
93H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 65 | US 40 | 99.80 |
| Lung Cancer Treatments and Mutations | Lifetime | 126 | US 68 | 99.63 |
| CAR-T cell therapy research | Lifetime | 166 | US 104 | 99.40 |
| Lung Cancer Research Studies | Lifetime | 130 | US 71 | 99.42 |
| Immunotherapy and Immune Responses | Lifetime | 508 | US 272 | 99.17 |
| Peptidase Inhibition and Analysis | Lifetime | 362 | US 171 | 98.59 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 788 | US 355 | 98.07 |
| Colorectal Cancer Treatments and Studies | Lifetime | 675 | US 283 | 98.04 |
| Cancer Research and Treatments | Lifetime | 800 | US 423 | 96.36 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 414 | US 189 | 92.54 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 360 | US 139 | 98.62 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 288 | US 112 | 98.12 |